Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MyCyFAPP WP3 predictive model for pancreatic enzyme replacement in children with cystic fibrosis
NL-OMON46193Not yet recruiting
- Sponsor
- Kindergeneeskunde
- Start
- Mar 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in cystic fibrosis (CF) and exocrine pancreatic insufficiency (EPI), sponsored by Kindergeneeskunde. Primary endpoint: Model development endpoint. Planned start Mar 2016; status: not yet recruiting.
02
Conditions
cystic fibrosis (CF)exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NL-OMON46193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46193.